Merck’s Vioxx scandal widens: Drug maker knew Vioxx was deadly for years before risk was made public | WHAT REALLY HAPPENED


Merck’s Vioxx scandal widens: Drug maker knew Vioxx was deadly for years before risk was made public

The Vioxx scandal widened this week as new research published in the Archives of Internal Medicine reveals that Vioxx maker Merck held data for three years that proved Vioxx caused an alarming increase in the risk of heart attacks and strokes. And yet Merck chose not to release that data. In fact, it took three more years of patients dying from heart attacks before Vioxx was pulled off the market, and even then, Merck insisted the drug was not dangerous.

This new study was based on a meta-analysis of several unpublished studies that Merck obviously didn’t want to see published in medical journals. Drug companies routinely engage in this subterfuge: They cherry-pick which studies they want published while burying the rest. They also choose which studies to forward to the FDA, all while claiming the whole charade is based on “evidence-based medicine.”

Webmaster's Commentary: 

Drug companies which engage in this kind of "research" which leads to potentially dangerous, life-threatening outcomes, should be sued out of existence.

Comments

SHARE THIS ARTICLE WITH YOUR SOCIAL MEDIA